Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Targeting phosphatidylserine to enhance immunogenicity of regulated necrotic cancer cells by microcapsules.
Information
Project Team
Organisations
Outputs & Impact
Publications & research data ( 6 )
The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments
Thijs Van de Vyver
Cristina Muntean
Iuliia Efimova
Dmitri Krysko
Lynn De Backer
Stefaan De Smedt
Koen Raemdonck
A1
Journal Article
in
JOURNAL OF CONTROLLED RELEASE
2023
Mechanobiology of ferroptotic cancer cells as a novel 'eat-me' signal : regulating efferocytosis through layer-by-layer coating
Louis Van der Meeren
Iuliia Efimova
Robin Demuynck
Bogdan Parakhonskiy
Dmitri Krysko
Andre Skirtach
A1
Journal Article
in
ADVANCED HEALTHCARE MATERIALS
2023
Ferroptosis : friend or foe in cancer immunotherapy?
Robin Demuynck
Iuliia Efimova
Elena Catanzaro
Dmitri Krysko
Editorial material
2023
In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment
Dmitri Krysko
Robin Demuynck
Iuliia Efimova
Faye Naessens
Olga Krysko
Elena Catanzaro
A1
Journal Article
in
CELLS
2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
Maria Vedunova
Victoria Turubanova
Olga Vershinina
Mariia Saviuk
Iuliia Efimova
Tatiana Mishchenko
Robrecht Raedt
Anne Vral
Christian Vanhove
Daria Korsakova
et al.
A1
Journal Article
in
CELL DEATH & DISEASE
2022
Immunogenic ferroptosis and where to find it?
Robin Demuynck
Iuliia Efimova
Faye Naessens
Dmitri Krysko
A1
Journal Article
in
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2021
Activities ( 0 )
Results
Impact narratives ( 0 )
Patents ( 0 )